Direct-acting Antiviral in the Treatment of Chronic Hepatitis C: Bonuses and Challenges

Owing to the rapid development and wide clinical application of direct acting antiviral (DAA) drugs in the treatment of hepatitis C virus (HCV) infection, the era of interferon-based therapy has almost come to an end. Cumulative studies show that DAA therapy renders high cure efficiency (>90%) an...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Haiyan, Li, Lei, Hou, Zhouhua, Zhang, Yapeng, Tang, Zhongxiang, Liu, Shuiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7163356/
https://www.ncbi.nlm.nih.gov/pubmed/32308542
http://dx.doi.org/10.7150/ijms.43079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7163356/
https://www.ncbi.nlm.nih.gov/pubmed/32308542
http://dx.doi.org/10.7150/ijms.43079

Ejemplares similares